The Trump administration has unveiled sweeping new health guidance aimed at tackling autism in the United States, combining warnings about the painkiller paracetamol with the promotion of leucovorin, a decades-old drug now repurposed to treat a rare neurological condition with autistic features.
The announcement, hailed by supporters as bold but criticised by experts as premature, underscores the administration's pledge to confront what officials call America's 'skyrocketing rates of autism'.
